42
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Primary hyperparathyroidism (PHPT) is a relatively rare disorder among children, adolescents and young adults. Its development at an early age is suspicious for hereditary causes, though the need for routine genetic testing remains controversial.

          Objective

          To identify and describe hereditary forms of PHPT in patients with manifestation of the disease under 40 years of age.

          Design

          We enrolled 65 patients with PHPT diagnosed before 40 years of age. Ten of them had MEN1 mutation, and PHPT in them was the first manifestation of multiple endocrine neoplasia type 1 syndrome.

          Methods

          The other fifty-five patients underwent next-generation sequencing (NGS) of a custom-designed panel of genes, associated with PHPT ( MEN1, CASR, CDC73, CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2C, CDKN2D). In cases suspicious for gross CDC73 deletions multiplex ligation-dependent probe amplification was performed.

          Results

          NGS revealed six pathogenic or likely pathogenic germline sequence variants: four in CDC73 c.271C>T (p.Arg91*), c.496C>T (p.Gln166*), c.685A>T (p.Arg229*) and c.787C>T (p.Arg263Cys); one in CASR c.3145G>T (p.Glu1049*) and one in MEN1 c.784-9G>A. In two patients, MLPA confirmed gross CDC73 deletions. In total, 44 sporadic and 21 hereditary PHPT cases were identified. Parathyroid carcinomas and atypical parathyroid adenomas were present in 8/65 of young patients, in whom CDC73 mutations were found in 5/8.

          Conclusions

          Hereditary forms of PHPT can be identified in up to 1/3 of young patients with manifestation of the disease at <40 years of age. Parathyroid carcinomas or atypical parathyroid adenomas in young patients are frequently associated with CDC73 mutations.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Positional cloning of the gene for multiple endocrine neoplasia-type 1.

          Multiple endocrine neoplasia-type 1 (MEN1) is an autosomal dominant familial cancer syndrome characterized by tumors in parathyroids, enteropancreatic endocrine tissues, and the anterior pituitary. DNA sequencing from a previously identified minimal interval on chromosome 11q13 identified several candidate genes, one of which contained 12 different frameshift, nonsense, missense, and in-frame deletion mutations in 14 probands from 15 families. The MEN1 gene contains 10 exons and encodes a ubiquitously expressed 2.8-kilobase transcript. The predicted 610-amino acid protein product, termed menin, exhibits no apparent similarities to any previously known proteins. The identification of MEN1 will enable improved understanding of the mechanism of endocrine tumorigenesis and should facilitate early diagnosis.
            • Record: found
            • Abstract: not found
            • Article: not found

            Clinical review 122: Parathyroid carcinoma.

            E Shane (2001)
              • Record: found
              • Abstract: found
              • Article: not found

              Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

              Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem. The purpose of this report is to provide an update on the use of diagnostic tests for this condition in clinical practice. This subgroup was constituted by the Steering Committee to address key questions related to the diagnosis of PHPT. Consensus was established at a closed meeting of the Expert Panel that followed. Each question was addressed by a relevant literature search (on PubMed), and the data were presented for discussion at the group meeting. Consensus was achieved by a group meeting. Statements were prepared by all authors, with comments relating to accuracy from the diagnosis subgroup and by representatives from the participating professional societies. We conclude that: 1) reference ranges should be established for serum PTH in vitamin D-replete healthy individuals; 2) second- and third-generation PTH assays are both helpful in the diagnosis of PHPT; 3) normocalcemic PHPT is a variant of the more common presentation of PHPT with hypercalcemia; 4) serum 25-hydroxyvitamin D concentrations should be measured and, if vitamin D insufficiency is present, it should be treated as part of any management course; 5) genetic testing has the potential to be useful in the differential diagnosis of familial hyperparathyroidism or hypercalcemia.

                Author and article information

                Journal
                Endocr Connect
                Endocr Connect
                EC
                Endocrine Connections
                Bioscientifica Ltd (Bristol )
                2049-3614
                November 2017
                04 September 2017
                : 6
                : 8
                : 557-565
                Affiliations
                [1 ]Department of Neuroendocrinology and Bone Diseases Endocrinology Research Center, Moscow, Russian Federation
                [2 ]Department of Parathyroid Diseases Endocrinology Research Center, Moscow, Russian Federation
                [3 ]Department and Laboratory of Inherited Endocrine Disorders Endocrinology Research Center, Moscow, Russian Federation
                [4 ]Department of Surgery Endocrinology Research Center, Moscow, Russian Federation
                [5 ]I.M. Sechenov First Moscow State Medical University Moscow, Russian Federation
                [6 ]Institute of Clinical Endocrinology Endocrinology Research Center, Moscow, Russian Federation
                [7 ]Endocrinology Research Center Moscow, Russian Federation
                Author notes
                Correspondence should be addressed to E Mamedova; Email: elisabetta_2010@ 123456mail.ru
                Article
                EC170126
                10.1530/EC-17-0126
                5633061
                28870973
                73914c9d-1dba-48b2-afc6-0cb72b054c74
                © 2017 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License.

                History
                : 4 September 2017
                : 4 September 2017
                Categories
                Research

                primary hyperparathyroidism,hyperparathyroidism-jaw tumor syndrome,multiple endocrine neoplasia 1,familial isolated hyperparathyroidism,cdc73

                Comments

                Comment on this article

                Related Documents Log